In the 2003 panel decision in Schering Corp. v. Geneva Pharm., Inc., the panel rejected “the contention that inherent anticipation requires recognition [of the claim element not found] in the prior art.” The claims were directed to a bioactive metabolite … Continue reading
The post Millennium Pharm. v. Sandoz, Inc. – Revenge of the Chemical Judges appeared first on Patents4Life | Warren Woessner.